Influence of Type 1 Diabetes Genes on Disease Progression: Similarities and Differences Between Countries
- 323 Downloads
Type 1 diabetes (T1D) is an autoimmune disease causing the destruction of pancreatic beta cells. The onset of clinical T1D is preceded by a time period called pre-diabetes, the duration of which varies widely. However, not all subjects developing beta-cell autoimmunity progress to clinical T1D. The inherited risk for T1D is determined by the human leukocyte antigen (HLA) class II genes, HLA class I genes, and several loci outside the HLA area. Although the role of the genetic risk variants in disease pathogenesis is not completely understood, some of the variants affecting disease risk are thought to influence the initiation of beta-cell autoimmunity whereas others seem to play a role during the later stages of the autoimmune process. In this review we describe the current knowledge on the genetic factors mediating the fate of already-established beta-cell autoimmunity and the rate of beta-cell destruction.
KeywordsType 1 diabetes Disease progression Genes HLA PTPN22 IFIH1
This work was supported by the Academy of Finland, the Sigrid Jusélius Foundation and the Finnish Medical Foundation.
No potential conflicts of interest relevant to this article were reported.
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
- 15.Sabbah E, Savola K, Kulmala P, Reijonen H, Veijola R, Vahasalo P, et al. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group. Clin Exp Immunol. 1999;116:78–83.PubMedCrossRefGoogle Scholar
- 17.Vandewalle CL, Decraene T, Schuit FC, De Leeuw IH, Pipeleers DG, Gorus FK. Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. The Belgian Diabetes Registry. Diabetologia. 1993;36:1155–62.PubMedCrossRefGoogle Scholar
- 22.Kondrashova A, Viskari H, Kulmala P, Romanov A, Ilonen J, Hyöty H, et al. Signs of beta-cell autoimmunity in nondiabetic schoolchildren: a comparison between Russian Karelia with a low incidence of type 1 diabetes and Finland with a high incidence rate. Diabetes Care. 2007;30:95–100.PubMedCrossRefGoogle Scholar
- 23.Schlosser M, Strebelow M, Wassmuth R, Arnold ML, Breunig I, Rjasanowski I, et al. The Karlsburg type 1 diabetes risk study of a normal schoolchild population: association of beta-cell autoantibodies and human leukocyte antigen-DQB1 alleles in antibody-positive individuals. J Clin Endocrinol Metab. 2002;87:2254–61.PubMedCrossRefGoogle Scholar
- 27.•• Lipponen K, Gombos Z, Kiviniemi M, Siljander H, Lempainen J, Hermann R et al. Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes. Diabetes. 2010;59:3253–6. This paper from the Finnish DIPP study demonstrated that the HLA class I alleles A*03 and B*39 affect the rate of progression to clinical T1D after the initiation of beta-cell autoimmunity.Google Scholar
- 31.•• Steck AK, Zhang W, Bugawan TL, Barriga KJ, Blair A, Erlich HA et al. Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR,DQ genotypes? Diabetes. 2009;58:1028–33. This paper from the DAISY study, Colorado, U.S. analyzed the effect of non-HLA polymorphisms on disease progression after signs of beta-cell autoimmunity. No effect of the snps analyzed on disease progression was observed.Google Scholar
- 32.•• Winkler C, Lauber C, Adler K, Grallert H, Illig T, Ziegler AG, et al. An interferon-induced helicase (IFIH1) gene polymorphism associates with different rates of progression from autoimmunity to type 1 diabetes. Diabetes. 2011;60:685–90. This paper from the German BABYDIAB study reports the accelerating effect of the IFIH1 gene snp on the progression of beta-cell destruction after the appearance of islet autoimmunity.Google Scholar
- 33.•• Lempainen J, Hermann R, Veijola R, Simell O, Knip M, Ilonen J. Effect of the PTPN22 and INS risk genotypes on the progression to clinical type 1 diabetes after the initiation of beta-cell autoimmunity. Diabetes. 2012;61:963–6. This paper from the Finnish DIPP study reports the enhancing effect of the PTPN22 gene polymorphism on progression to clinical T1D after the establishment of beta-cell autoimmunity.Google Scholar
- 53.Kukko M, Kimpimäki T, Korhonen S, Kupila A, Simell S, Veijola R, et al. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population. J Clin Endocrinol Metab. 2005;90:2712–7.PubMedCrossRefGoogle Scholar
- 55.Pugliese A, Zeller M, Fernandez Jr A, Zalcberg LJ, Bartlett RJ, Ricordi C, et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet. 1997;15:293–7.PubMedCrossRefGoogle Scholar